{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:24:24Z","timestamp":1773285864047,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T00:00:00Z","timestamp":1365120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00381-013-2086-8","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T09:05:31Z","timestamp":1365066331000},"page":"1097-1105","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of neuroblastoma bone invasion\/metastasis in established bone metastatic model of SY5Y and KCNR cell lines"],"prefix":"10.1007","volume":"29","author":[{"given":"Hongyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weisong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuke","family":"Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debao","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"2086_CR1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-006-9028-9","volume":"25","author":"T Ara","year":"2006","unstructured":"Ara T, DeClerck YA (2006) Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25:645\u2013657","journal-title":"Cancer Metastasis Rev"},{"key":"2086_CR2","first-page":"293","volume":"27","author":"JL Armstrong","year":"2012","unstructured":"Armstrong JL, Martin S, Illingworth NA, Jamieson D, Neilson A, Lovat PE, Redfern CP, Veal GJ (2012) The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide. Oncol Rep 27:293\u2013298","journal-title":"Oncol Rep"},{"key":"2086_CR3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11060-010-0209-6","volume":"100","author":"A Bilir","year":"2010","unstructured":"Bilir A, Erguven M, Yazihan N, Aktas E, Oktem G, Sabanci A (2010) Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y. J Neurooncol 100:385\u2013395","journal-title":"J Neurooncol"},{"key":"2086_CR4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203\u2013216","journal-title":"Nat Rev Cancer"},{"key":"2086_CR5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1476-4598-8-126","volume":"8","author":"AJ Carlisle","year":"2009","unstructured":"Carlisle AJ, Lyttle CA, Carlisle RY, Maris JM (2009) CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation. Mol Canc 8:126","journal-title":"Mol Canc"},{"key":"2086_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.morpho.2011.02.004","volume":"95","author":"D Chappard","year":"2011","unstructured":"Chappard D, Bouvard B, Basl\u00e9 MF, Legrand E, Audran M (2011) Bone metastasis: histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review. Morphologie 95:65\u201375","journal-title":"Morphologie"},{"key":"2086_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0972-3919.78249","volume":"25","author":"M Chawla","year":"2010","unstructured":"Chawla M, Kumar R, Agarwala S, Bakhshi S, Gupta DK, Malhotra (2010) A Role of positron emission tomography-computed tomography in staging and early chemotherapy response evaluation in children with neuroblastoma. Indian J Nucl Med 25:147\u2013155","journal-title":"Indian J Nucl Med"},{"key":"2086_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.sempedsurg.2011.10.009","volume":"21","author":"AM Davidoff","year":"2012","unstructured":"Davidoff AM (2012) Neuroblastoma. Semin Pediatr Surg 21:2\u201314","journal-title":"Semin Pediatr Surg"},{"key":"2086_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11060-010-0491-3","volume":"104","author":"A Dickey","year":"2011","unstructured":"Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, Thotala DK (2011) GSK-3\u03b2 inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line. J Neurooncol 104:145\u2013153","journal-title":"J Neurooncol"},{"key":"2086_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12020-009-9285-9","volume":"37","author":"A Enjuanes","year":"2010","unstructured":"Enjuanes A, Ruiz-Gasp\u00e0 S, Peris P, Ozalla D, \u00c1lvarez L, Combalia A, Mart\u00ednez de Osaba MJ, Monegal A, Pares A, Gua\u00f1abens N (2010) The effect of the alendronate on OPG\/RANKL system in differentiated primary human osteoblasts. Endocrine 37:180\u2013186","journal-title":"Endocrine"},{"key":"2086_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2010.06.028","volume":"48","author":"D Granchi","year":"2011","unstructured":"Granchi D, Corrias MV, Garaventa A, Bagl\u00eco SR, Cangemi G, Carlini B, Paolucci P, Giunti A, Baldini N (2011) Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels. Bone 48:152\u2013159","journal-title":"Bone"},{"key":"2086_CR12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clon.2011.12.003","volume":"24","author":"KY Gulenchyn","year":"2012","unstructured":"Gulenchyn KY, Yao X, Asa SL, Singh S, Law C (2012) Radionuclide therapy in neuroendocrine tumours: a systematic review. Clin Oncol (R Coll Radiol) 24:294\u2013308","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2086_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.suronc.2007.09.005","volume":"16","author":"TA Ishola","year":"2007","unstructured":"Ishola TA, Chung DH (2007) Neuroblastoma. Surg Oncol 16:149\u2013156","journal-title":"Surg Oncol"},{"key":"2086_CR14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jcp.2010.086595","volume":"64","author":"S Jabbar","year":"2011","unstructured":"Jabbar S, Drury J, Fordham JN, Datta HK, Francis RM, Tuck SP (2011) Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J Clin Pathol 64:354\u2013357","journal-title":"J Clin Pathol"},{"key":"2086_CR15","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1158\/1535-7163.MCT-11-0326","volume":"10","author":"T Klymenko","year":"2011","unstructured":"Klymenko T, Brandenburg M, Morrow C, Dive C, Makin G (2011) The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxia-induced drug resistance in neuroblastoma cells. Mol Cancer Ther 10:2373\u20132383","journal-title":"Mol Cancer Ther"},{"key":"2086_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2011.06.028","volume":"312","author":"M Ma","year":"2011","unstructured":"Ma M, Ye JY, Deng R, Dee CM, Chan GC (2011) Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1\/CXCR4 and SDF-1\/CXCR7 signaling. Cancer Lett 312:1\u201310","journal-title":"Cancer Lett"},{"key":"2086_CR17","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"JM Maris","year":"2007","unstructured":"Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106\u20132120","journal-title":"Lancet"},{"key":"2086_CR18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.bjc.6605621","volume":"102","author":"KK Matthay","year":"2010","unstructured":"Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, Pearson AD, Cohn SL (2010) Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 102:1319\u20131326","journal-title":"Br J Cancer"},{"key":"2086_CR19","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1371\/journal.pone.0001016","volume":"2","author":"R Meier","year":"2007","unstructured":"Meier R, M\u00fchlethaler-Mottet A, Flahaut M, Coulon A, Fusco C, Louache F, Auderset K, Bourloud KB, Daudigeos E, Ruegg C, Vassal G, Gross N, Joseph JM (2007) The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion. PLoS One 2:e1016","journal-title":"PLoS One"},{"key":"2086_CR20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bone.2011.09.054","volume":"50","author":"Z Ostrowska","year":"2012","unstructured":"Ostrowska Z, Ziora K, O\u015bwi\u0119cimska J, Swi\u0119tochowska E, Szapska B, Wo\u0142kowska-Pokrywa K, Dyduch A (2012) RANKL\/RANK\/OPG system and bone status in females with anorexia nervosa. Bone 50:156\u2013160","journal-title":"Bone"},{"key":"2086_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcl.2007.10.014","volume":"55","author":"JR Park","year":"2008","unstructured":"Park JR, Eggert A, Caron H (2008) Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55:97\u2013120","journal-title":"Pediatr Clin North Am"},{"key":"2086_CR22","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1200\/JCO.2010.34.3293","volume":"29","author":"JR Park","year":"2011","unstructured":"Park JR, Scott JR, Stewart CF, London WB, Naranjo A, Santana VM, Shaw PJ, Cohn SL, Matthay KK (2011) Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study. J Clin Oncol 29:4351\u20134357","journal-title":"J Clin Oncol"},{"issue":"19","key":"2086_CR23","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1158\/0008-5472.CAN-06-4508","volume":"67","author":"H Peng","year":"2007","unstructured":"Peng H, Sohara Y, Moats RA, Nelson MD Jr, Groshen SG, Ye W, Reynolds CP, DeClerck YA (2007) The activity of zoledronic acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation. Cancer Res 67(19):9346\u20139355","journal-title":"Cancer Res"},{"key":"2086_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1469-8749.2011.04174.x","volume":"54","author":"A Poretti","year":"2012","unstructured":"Poretti A, Grotzer MA (2012) Neuroblastoma with spinal cord compression: is there an emergency treatment of choice? Dev Med Child Neurol 54:297\u2013298","journal-title":"Dev Med Child Neurol"},{"key":"2086_CR25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:655\u2013664","journal-title":"N Engl J Med"},{"key":"2086_CR26","first-page":"19","volume":"26","author":"H Sartelet","year":"2012","unstructured":"Sartelet H, Durrieu L, Fontaine F, Nyalendo C, Haddad E (2012) Description of a new xenograft model of metastatic neuroblastoma using NOD\/SCID\/Il2rg null (NSG) mice. In Vivo 26:19\u201329","journal-title":"In Vivo"},{"key":"2086_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.semcancer.2011.09.012","volume":"21","author":"RC Seeger","year":"2011","unstructured":"Seeger RC (2011) Immunology and immunotherapy of neuroblastoma. Semin Cancer Biol 21:229\u2013237","journal-title":"Semin Cancer Biol"},{"key":"2086_CR28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/j.semnuclmed.2011.05.001","volume":"41","author":"SE Sharp","year":"2011","unstructured":"Sharp SE, Gelfand MJ, Shulkin BL (2011) Pediatrics: diagnosis of neuroblastoma. Semin Nucl Med 41:345\u2013353","journal-title":"Semin Nucl Med"},{"key":"2086_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2005.01.059","volume":"228","author":"Y Sohara","year":"2005","unstructured":"Sohara Y, Shimada H, DeClerck YA (2005) Mechanisms of bone invasion and metastasis in human neuroblastoma. Cancer Lett 228:203\u2013209","journal-title":"Cancer Lett"},{"key":"2086_CR30","first-page":"3026","volume":"63","author":"Y Sohara","year":"2003","unstructured":"Sohara Y, Shimada H, Scadeng M, Pollack H, Yamada S, Ye W, Reynolds CP, DeClerck YA (2003) Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate. Cancer Res 63:3026\u20133031","journal-title":"Cancer Res"},{"key":"2086_CR31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","volume":"7","author":"LJ Suva","year":"2011","unstructured":"Suva LJ, Washam C, Nicholas RW, Griffin RJ (2011) Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7:208\u2013218","journal-title":"Nat Rev Endocrinol"},{"key":"2086_CR32","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1200\/JCO.2011.35.9570","volume":"29","author":"DR Taggart","year":"2011","unstructured":"Taggart DR, London WB, Schmidt ML, DuBois SG, Monclair TF, Nakagawara A, De Bernardi B, Ambros PF, Pearson AD, Cohn SL, Matthay KK (2011) Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18\u00a0months of age. J Clin Oncol 29:4358\u20134364","journal-title":"J Clin Oncol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-013-2086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-013-2086-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-013-2086-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T09:45:35Z","timestamp":1715161535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-013-2086-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,5]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1007\/s00381-013-2086-8","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,5]]}}}